Pezzolo, E. (2026) “Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis)”, Acta Dermato-Venereologica, 106, pp. adv–2025. doi: 10.2340/actadv.v106.adv-2025-0193.